Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-26 @ 12:52 AM
Study NCT ID:
NCT00244634
Status:
COMPLETED
Last Update Posted:
2007-12-19
First Post:
2005-10-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-25
First Submit QC Date:
None
Study First Post Date:
2005-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-12-17
Last Update Post Date:
2007-12-19
Last Update Post Date Type:
ESTIMATED